TAI:6446

PharmaEssentia Corporation · TAI · Healthcare · TWD · FY for 2025

Figures on this page computed 2026-11-08 12:48 UTC

Last close

n/aTWD

Market data

93.1xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
TWD
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
32.3%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
21.6%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
0.03Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
TWD
- computed

Price is the furthest below its sector's middle: 0.05 against 0.36 on the market's range.

Five bars, one line

lens 7 of 9

4.48x

-21.50x

-5.10x

1.31x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales4.48x
Its own average over 10 years, 3.49B.
Profit-21.50x
Its own average over 10 years, -234.7M.
Free cash flow-5.10x
Its own average over 10 years, -661.1M.
Debt1.31x
Its own average over 10 years, 651.6M.
Pricen/a
Its own average over 0 years. Market data

Profit is furthest from its own average, at -21.50 times.

Sales is 4.48 times its own 10-year average; Profit is -21.50 times its own 10-year average; Free cash flow is -5.10 times its own 10-year average; Debt is 1.31 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales against its own 10-year average4.48
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Profit against its own 10-year average-21.50
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Free cash flow against its own 10-year average-5.10
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Debt against its own 10-year average1.31
Source
computed
Statement
income
Fiscal year
2025
Reported in
TWD
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
TWD